CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: PROF. KHALID MUBARAK AL-SHAFI

World / Asia

Researchers in Australia to develop gene therapy platform for rare diseases

Published: 16 Nov 2026 - 01:49 pm | Last Updated: 16 Nov 2026 - 01:50 pm

Xinhua

Melbourne, Australia: Researchers in Australia will develop a personalized gene therapy platform to treat hundreds of rare blood and immune disorders caused by genetic mutations.

The five-year project, led by Australia's Walter and Eliza Hall Institute of Medical Research (WEHI), will combine a "patient avatar" in the lab developed from patients' blood samples with prime editing technology to precisely repair disease-causing DNA changes, according to a WEHI statement released on Sunday.

More than 600 distinct blood and immune diseases are caused by tiny errors in the genetic code within blood stem cells. These conditions are rare but often severe and life-limiting, and collectively affect millions of people worldwide, the statement said.

The WEHI team has developed a "blood in a dish" system that uses stem cells collected from a patient's blood sample to recreate key parts of blood and immune development outside the body. This patient avatar allows researchers to see what's going wrong for individual patients and to test whether a specific genetic fix can restore normal function.

The approach is designed to make personalized medicine practical for diseases that have never attracted large-scale investment, said project chief investigator Professor Shalin Naik, a WEHI laboratory head.